Alpine Immune Sciences, Inc.Alpine Immune Sciences, Inc.Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

No trades
See on Supercharts
Market capitalization
‪4.23 B‬USD
−0.69USD
‪−32.18 M‬USD
‪58.88 M‬USD
‪47.05 M‬
Beta (1Y)
3.33

About Alpine Immune Sciences, Inc.

CEO
Mitchell H. Gold
Headquarters
Seattle
Employees (FY)
142
Founded
2007
ISIN
US02083G1004
FIGI
BBG001J2LL66
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which focusses on discovering and developing innovative, protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ALPN is 64.43 USD — it has decreased by 0.05% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Alpine Immune Sciences, Inc. stocks are traded under the ticker ALPN.
Alpine Immune Sciences, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
ALPN stock is 0.09% volatile and has beta coefficient of 3.33. Check out the list of the most volatile stocks — is Alpine Immune Sciences, Inc. there?
One year price forecast for Alpine Immune Sciences, Inc. has a max estimate of 65.00 USD and a min estimate of 65.00 USD.
ALPN earnings for the last quarter are −0.24 USD whereas the estimation was −0.33 USD which accounts for 28.21% surprise. Estimated earnings for the next quarter are −0.33 USD. See more details about Alpine Immune Sciences, Inc. earnings.
Alpine Immune Sciences, Inc. revenue for the last quarter amounts to ‪10.04 M‬ USD despite the estimated figure of ‪7.25 M‬ USD. In the next quarter revenue is expected to reach ‪9.10 M‬ USD.
Yes, you can track Alpine Immune Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
ALPN stock has risen by 0.39% compared to the previous week, the month change is a 72.27% rise, over the last year Alpine Immune Sciences, Inc. has showed a 762.52% increase.
ALPN net income for the last quarter is ‪5.96 M‬ USD, while the quarter before that showed ‪−11.72 M‬ USD of net income which accounts for 150.84% change. Track more Alpine Immune Sciences, Inc. financial stats to get the full picture.
Today Alpine Immune Sciences, Inc. has the market capitalization of ‪4.23 B‬, it has decreased by 1.73% over the last week.
No, ALPN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALPN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alpine Immune Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ALPN reached its all-time high on Aug 21, 2015 with the price of 81.72 USD, and its all-time low was 2.05 USD and was reached on Mar 19, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 142.00 employees. See our rating of the largest employees — is Alpine Immune Sciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Alpine Immune Sciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Alpine Immune Sciences, Inc. stock shows the strong buy signal. See more of Alpine Immune Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Alpine Immune Sciences, Inc. future price: according to them, ALPN price has a max estimate of 65.00 USD and a min estimate of 65.00 USD. Read a more detailed Alpine Immune Sciences, Inc. forecast: see what analysts think of Alpine Immune Sciences, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Alpine Immune Sciences, Inc. EBITDA is ‪−43.67 M‬ USD, and current EBITDA margin is −74.18%. See more stats in Alpine Immune Sciences, Inc. financial statements.